Close Menu

NEW YORK (GenomeWeb News) – Population Genetics today announced the closing of a Series B financing round that brought in $5.7 million.

The funds will be used to complete validation of the company's technology, "setting the stage for a future major financing aimed at making that technology broadly available," the UK-based firm said in a statement.

Syngenta Ventures, the VC arm of Syngenta, was a new investor in the round, and joined existing investors Compass Genetics Investors, the Wellcome Trust, Auriga Partners, and Beringea.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.